Michael J. Graziano

Pharmacodynamic and toxicokinetic evaluation of the novel MEK inhibitor, PD0325901, in the rat following oral and intravenous administration

Alan Brown, Tage Carlson, Cho‐Ming Loi et al. · Cancer Chemotherapy and Pharmacology · 2006 · 124 citations

Intravenous Administration, Pharmacological Study, Medicine +8

Carcinogenicity Risk Assessment Supports the Chronic Safety of Dapagliflozin, an Inhibitor of Sodium–Glucose Co-Transporter 2, in the Treatment of Type 2 Diabetes Mellitus

Timothy P. Reilly, Michael J. Graziano, Evan B. Janovitz et al. · Diabetes Therapy · 2014 · 62 citations · Full text

Endothal and cantharidin analogs: relation of structure to herbicidal activity and mammalian toxicity

Masafumi Matsuzawa, Michael J. Graziano, John E. Casida · Journal of Agricultural and Food Chemistry · 1987 · 52 citations

Biochemistry, Medicine, Herb-drug Interaction +11

Cartilage Dysplasia and Tissue Mineralization in the Rat Following Administration of a FGF Receptor Tyrosine Kinase Inhibitor

Alan Brown, Cynthia L. Courtney, Lena M. King et al. · Toxicologic Pathology · 2005 · 52 citations

Partial characterization of specific cantharidin binding sites in mouse tissues.

Michael J. Graziano, I N Pessah, Masafumi Matsuzawa et al. · Molecular Pharmacology · 1988 · 42 citations